ACUTUS MEDICAL, INC. Financials Acutus Medical, Inc.
Equities
AFIB
US0051111096
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1665 USD | +1.90% |
|
-2.06% | -17.53% |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| Apr. 01 | Acutus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 802.2 | 95.32 | 32.72 | 5.916 |
| Enterprise Value (EV) 1 | 703.5 | 32.83 | 1.129 | 21.99 |
| P/E ratio | -3.22 x | -0.83 x | -0.82 x | -0.07 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 94.8 x | 5.52 x | 2 x | 0.83 x |
| EV / Revenue | 83.1 x | 1.9 x | 0.07 x | 3.07 x |
| EV / EBITDA | -7.99 x | -0.3 x | -0.01 x | -1.07 x |
| EV / FCF | -9,420,554 x | -456,245 x | -16,754 x | 2,690,699 x |
| FCF Yield | -0% | -0% | -0.01% | 0% |
| Price to Book | 6.37 x | 0.9 x | 0.44 x | -6.73 x |
| Nbr of stocks (in thousands) | 27,846 | 27,953 | 28,452 | 29,304 |
| Reference price 2 | 28.81 | 3.410 | 1.150 | 0.2019 |
| Announcement Date | 3/19/21 | 3/30/22 | 3/24/23 | 4/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2.166 | 2.836 | 8.464 | 17.26 | 16.36 | 7.164 |
| EBITDA 1 | -35.63 | -53.73 | -88.02 | -109.5 | -84.87 | -20.49 |
| EBIT 1 | -37.75 | -56.08 | -91.24 | -115.9 | -91.35 | -20.68 |
| Operating Margin | -1,742.89% | -1,977.54% | -1,077.93% | -671.19% | -558.3% | -288.74% |
| Earnings before Tax (EBT) 1 | -47.91 | -97.04 | -102 | -117.7 | -39.53 | -11.86 |
| Net income 1 | -47.91 | -97.04 | -102 | -117.7 | -39.62 | -81.66 |
| Net margin | -2,211.77% | -3,421.69% | -1,204.88% | -681.71% | -242.11% | -1,139.91% |
| EPS 2 | -87.77 | -144.4 | -8.940 | -4.107 | -1.399 | -2.807 |
| Free Cash Flow | - | -27.59 | -74.68 | -71.95 | -67.39 | 8.174 |
| FCF margin | - | -973% | -882.32% | -416.8% | -411.86% | 114.09% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/15/20 | 5/15/20 | 3/19/21 | 3/30/22 | 3/24/23 | 4/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4.601 | 4.362 | 3.681 | 4.076 | 3.644 | 4.962 | 4.17 | 5.289 | 5.238 |
| EBITDA 1 | -23.5 | -25.19 | -25.4 | -23.38 | -19.52 | 18.28 | -15.96 | -15.94 | -11.86 |
| EBIT 1 | -27.09 | -29.9 | -27.83 | 14.93 | -20.46 | 16.82 | -17.31 | -17.17 | -12.94 |
| Operating Margin | -588.76% | -685.47% | -756.13% | 366.24% | -561.5% | 339.06% | -415.04% | -324.65% | -246.96% |
| Earnings before Tax (EBT) 1 | -28.51 | -31.26 | -40.02 | 5.718 | -20.42 | 15.19 | -16.32 | -18.35 | -13.16 |
| Net income 1 | -28.51 | -31.26 | -40.02 | 5.718 | -20.42 | 15.11 | -16.32 | -18.35 | -13.24 |
| Net margin | -619.67% | -716.74% | -1,087.12% | 140.28% | -560.51% | 304.47% | -391.25% | -346.87% | -252.71% |
| EPS 2 | -0.9400 | -1.120 | -1.420 | 0.1600 | -0.7200 | 0.4100 | -0.5700 | -0.6300 | -0.4500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/21 | 3/30/22 | 5/12/22 | 8/11/22 | 11/10/22 | 3/16/23 | 5/11/23 | 8/7/23 | 11/8/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 8.12 | - | - | - | - | 16.1 |
| Net Cash position 1 | - | 30.7 | 98.7 | 62.5 | 31.6 | - |
| Leverage (Debt/EBITDA) | -0.2279 x | - | - | - | - | -0.7844 x |
| Free Cash Flow | - | -27.6 | -74.7 | -72 | -67.4 | 8.17 |
| ROE (net income / shareholders' equity) | - | -1,382% | -132% | -101% | -43.8% | -32.2% |
| ROA (Net income/ Total Assets) | - | -53.4% | -38.3% | -40% | -37.7% | -13.8% |
| Assets 1 | - | 181.9 | 266.5 | 294.4 | 105.2 | 591.9 |
| Book Value Per Share 2 | -201.0 | -324.0 | 4.520 | 3.780 | 2.630 | -0.0300 |
| Cash Flow per Share 2 | 14.70 | 13.60 | 0.9000 | 0.8600 | 0.9000 | 0.6500 |
| Capex 1 | 2.04 | 3.4 | 11.2 | 9.97 | 3.98 | 0.22 |
| Capex / Sales | 94.09% | 119.71% | 132.62% | 57.77% | 24.34% | 3.06% |
| Announcement Date | 5/15/20 | 5/15/20 | 3/19/21 | 3/30/22 | 3/24/23 | 4/1/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -17.53% | 4.95M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- AFIB Stock
- Financials Acutus Medical, Inc.
